Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burak Yulug

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Brain Research Bulletin|July 7, 2009
Neuroprotective treatment strategies for poststroke mood disorders: A minireview on atypical neuroleptic drugs and selective serotonin re-uptake inhibitorsBurak Yulug
Current Clinical Pharmacology|July 25, 2016
Pramipexole Responsive Neck Numbness: The Therapeutic Role of Dopamine Agonists in the Spinal Cord Indicating to a Common Spinal Pathophysiology with Restless Leg Syndrome (RLS)?Burak Yulug, Lütfü Hanoglu
Current Clinical Pharmacology|March 2, 2018
More Evidence for the Therapeutic Role of Pramipexole in Upper Limb Restlessness Due to Cervical Disc Pathology?Burak Yulug, Lutfu Hanoglu, Sema Brandmeier
Psychiatry and Clinical Neurosciences|May 20, 2017
Does sleep disturbance affect the amyloid clearance mechanisms in Alzheimer's disease?Burak Yulug, Lutfu Hanoglu, Ertugrul Kilic
Endocrine, Metabolic & Immune Disorders Drug Targets|April 11, 2022
The Savant Syndrome: a Gift or a Disability? A Deeper Look into Metabolic Correlates of Hidden Cognitive CapacityIrem Onin, Lütfü Hanoglu, Burak Yulug
Brain Research Bulletin|May 2, 2017
The neuroprotective effect of focused ultrasound: New perspectives on an old toolBurak Yulug, Lutfu Hanoglu, Ertugrul Kilic
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 27, 2014
The neuroprotective role of vesicular monoamine transporter 2 in neurodegenerative diseasesBurak Yulug, Lutfu Hanoglu, Ertugrul Kilic
Brain & Development|May 28, 2003
Childhood and juvenile onset multiple sclerosis: clinical and paraclinical featuresSerkan Ozakbas, Egemen Idiman, Baris Baklan, et al.
Brain Research|December 13, 2003
Rifampicin attenuates brain damage in focal ischemiaBurak Yulug, Ulkan Kilic, Ertugrul Kilic, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 11, 2007
Buprenorphine does not aggravate ischemic neuronal injury in experimental focal cerebral ischemiaBurak Yulug, Ertugrul Cam, Aysegul Yildiz, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Brain Research Bulletin|July 7, 2009
Neuroprotective treatment strategies for poststroke mood disorders: A minireview on atypical neuroleptic drugs and selective serotonin re-uptake inhibitorsBurak Yulug
Current Clinical Pharmacology|July 25, 2016
Pramipexole Responsive Neck Numbness: The Therapeutic Role of Dopamine Agonists in the Spinal Cord Indicating to a Common Spinal Pathophysiology with Restless Leg Syndrome (RLS)?Burak Yulug, Lütfü Hanoglu
Current Clinical Pharmacology|March 2, 2018
More Evidence for the Therapeutic Role of Pramipexole in Upper Limb Restlessness Due to Cervical Disc Pathology?Burak Yulug, Lutfu Hanoglu, Sema Brandmeier
Psychiatry and Clinical Neurosciences|May 20, 2017
Does sleep disturbance affect the amyloid clearance mechanisms in Alzheimer's disease?Burak Yulug, Lutfu Hanoglu, Ertugrul Kilic
Endocrine, Metabolic & Immune Disorders Drug Targets|April 11, 2022
The Savant Syndrome: a Gift or a Disability? A Deeper Look into Metabolic Correlates of Hidden Cognitive CapacityIrem Onin, Lütfü Hanoglu, Burak Yulug
Brain Research Bulletin|May 2, 2017
The neuroprotective effect of focused ultrasound: New perspectives on an old toolBurak Yulug, Lutfu Hanoglu, Ertugrul Kilic
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 27, 2014
The neuroprotective role of vesicular monoamine transporter 2 in neurodegenerative diseasesBurak Yulug, Lutfu Hanoglu, Ertugrul Kilic
Brain & Development|May 28, 2003
Childhood and juvenile onset multiple sclerosis: clinical and paraclinical featuresSerkan Ozakbas, Egemen Idiman, Baris Baklan, et al.
Brain Research|December 13, 2003
Rifampicin attenuates brain damage in focal ischemiaBurak Yulug, Ulkan Kilic, Ertugrul Kilic, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 11, 2007
Buprenorphine does not aggravate ischemic neuronal injury in experimental focal cerebral ischemiaBurak Yulug, Ertugrul Cam, Aysegul Yildiz, et al.
Pageof 9